Literature DB >> 7912004

Interleukin-1 augments the diminished interleukin-2 mRNA expression and proliferative response of neonatal T lymphocytes to anti-CD2 antibodies.

J Hassan1, D J Reen.   

Abstract

Expression of IL-2 mRNA by unstimulated and stimulated purified T cells and mononuclear cells from adult and cord blood was investigated in an attempt to better understand the underlying defective neonatal host immune defense system. Using RNA dot-blot analysis, IL-2 mRNA expression in anti-CD2-stimulated neonatal T cells revealed significantly reduced levels when compared to adult T cells (P < 0.01). Purified neonatal T cells also showed a significantly reduced proliferative response to anti-CD2 antibodies (P < 0.01). Addition of IL-1 beta enhanced the hyporesponsiveness of neonatal T cells at both the level of proliferation and IL-2 mRNA expression. Unseparated mononuclear cells from adult and cord blood revealed similar IL-2 mRNA levels and proliferation when activated by anti-CD2 stimulation. The reduced IL-2 mRNA expression observed in neonatal T cells may explain, in part, the difference in host defense between the newborn and adult during states of increased demand such as infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7912004     DOI: 10.1111/j.1365-3083.1994.tb03418.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  Reduced primary antigen-specific T-cell precursor frequencies in neonates is associated with deficient interleukin-2 production.

Authors:  J Hassan; D J Reen
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

2.  Signalling via CD28 of human naive neonatal T lymphocytes.

Authors:  J Hassan; S O'Neill; L A O'Neill; U Pattison; D J Reen
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

3.  Linkage of protein kinase C-beta activation and intracellular interleukin-2 accumulation in human naive CD4 T cells.

Authors:  J Hassan; E Rainsford; D J Reen
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.